Director, Clinical Product Management
Share role
The recipient sees their own assessment. Your profile and score are not shared.
About the role
H1 seeks a Director, Clinical Product Management in Copenhagen on a hybrid basis to lead the StudyHub clinical data platform roadmap in partnership with Novo Nordisk. The role covers stakeholder management, discovery and delivery, data product strategy, metrics, cross-functional leadership, and team growth. Requirements include 7+ years in product management, data product experience, regulated or enterprise experience, and clinical, pharma, or health data expertise.
Key requirements
- • At least 7 years of relevant experience
- • Required skills: Product management, Data product development or management, Stakeholder management, Product roadmap and strategy, Clinical data workflows, Product discovery and delivery, Product metrics and adoption tracking, Enterprise or client-embedded collaboration, Startup or scale-up experience, Cross-functional leadership, English fluency, Ability to work across US and European time zones
- • Required language: English
Opportunity details
- • Workplace: Hybrid
- • Posted: Jul 17, 2026
- • Original advert language: English
Full vacancy
HealthRoleIQ regularly verifies this opportunity against the employer’s posting and highlights the details relevant to your match.
See original vacancy ↗Employer’s role description
Job title: Director, Clinical Product Management
Department: Product
Team: Product Management
Location: Copenhagen
All locations: Copenhagen
Work type: Full time
Workplace type: hybrid
At H1, we believe access to the best healthcare information is a basic human right. Our mission is to provide a platform that can optimally inform every doctor interaction globally. This promotes health equity and builds needed trust in healthcare systems. To accomplish this our teams harness the power of data and AI-technology to unlock groundbreaking medical insights and convert those insights into action that result in optimal patient outcomes and accelerates an equitable and inclusive drug development lifecycle.